SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-15-004225
Filing Date
2015-04-30
Accepted
2015-04-30 16:31:37
Documents
12
Period of Report
2015-06-23
Effectiveness Date
2015-04-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2224488zdef14a.htm DEF 14A 593115
2 G651724.JPG g651724.jpg GRAPHIC 10236
3 G28654.JPG g28654.jpg GRAPHIC 6567
4 G407006.JPG g407006.jpg GRAPHIC 5158
5 G99002BEI001.GIF g99002bei001.gif GRAPHIC 108306
6 G99002BEI002.GIF g99002bei002.gif GRAPHIC 48060
7 G99002BGI001.GIF g99002bgi001.gif GRAPHIC 58460
8 G99002BGI002.GIF g99002bgi002.gif GRAPHIC 46378
9 G99002BKI001.GIF g99002bki001.gif GRAPHIC 45393
10 G99002BKI002.GIF g99002bki002.gif GRAPHIC 65651
11 G99002BKI003.GIF g99002bki003.gif GRAPHIC 28794
12 G99002BKI004.GIF g99002bki004.gif GRAPHIC 21385
  Complete submission text file 0001047469-15-004225.txt   1208091
Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 750 LEXINGTON AVENUE ELEVENTH FLOOR NEW YORK NY 10022 646-502-2311
STEMLINE THERAPEUTICS INC (Filer) CIK: 0001264587 (see all company filings)

IRS No.: 450522567 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35619 | Film No.: 15819217
SIC: 2834 Pharmaceutical Preparations